Novo says Wegovy injection reduced BMI and obesity rates in a trial of children
Novo said a trial found that Wegovy injections lowered body mass index and obesity rates in children; the drug is approved for children aged 12 and older, but no medication is approved for those under 12.Novo said a trial found that Wegovy injections lowered body mass index and obesity rates in children. The drug is already approved to treat obesity in children aged 12 and older, according to the supplied report. It adds that no medications are currently approved for children under 12. The report does not provide the trial’s size, results in detail or any next steps for seeking approval.
cnbc.com (English) ↗+ Save